Accuray Incorporated Overview
Pro stress-test →Accuray designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors globally. The company provides precision cancer treatment solutions through two primary platforms—CyberKnife robotic radiosurgery systems and TomoTherapy radiation therapy systems—serving hospitals and treatment facilities worldwide.
Strategic Profile
Pro stress-test →The company's flagship CyberKnife platform is a robotic stereotactic radiosurgery system used for treating primary and metastatic tumors outside the brain. The TomoTherapy platform, including the Radixact System, enables ultra-precise treatments for approximately 50 patients per day. The company operates with a direct-to-customer sales model supplemented by distributors and group purchasing organizations internationally.
Competitive Landscape
Pro stress-test →Accuray competes in the precision radiation therapy market with integrated treatment planning and delivery systems. Main competitors include larger medical device companies with radiation therapy portfolios. CyberKnife remains differentiated through its robotic delivery mechanism for stereotactic procedures, though competition exists in broader radiation oncology market from Varian (Siemens), Elekta, and others.
Industry Context
Accuray Incorporated operates in Medical Equipment Manufacturing - Radiation Oncology.
Key facts
Founded: 1990 · Headquarters: Madison, Wisconsin · Employees: 1,200 · Revenue: $750M · Market cap: $116.7M